Vitamin B6status and Administration During Radiation Therapy

  • H.-A Ladner
  • R. M. Salkeld
  • H.-A Ladner
Chapter
Part of the Experimental Biology and Medicine, Vol. 10 book series (EBAM, volume 10)

Abstract

It has been demonstrated in man and experimental animals by biochemical investigations with vitamin A and C during both carcinogenesis and cancer therapy that there is a correlation between the vitamin status of the host and the tumor growth. Similar findings have also been observed in vitamin B1, (RIVLIN 1975), B2 (BASU 1976) and B6 research.

Keywords

Kynurenic Acid Tryptophan Metabolism Xanthurenic Acid Urinary Steroid Tryptophan Metabolite 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    BASU, T.K.: Significance of vitamins in cancer. Oncology 33: 183–187 (1976)PubMedCrossRefGoogle Scholar
  2. 2.
    BELL, E.D.; BULBROOK, R.D.; HAYWARD, J.L.; TONG, D.: Tryptophan metabolism and recurrence rates of patients with breast cancer after mastectomy. Acta vitamin, enzymol. 29: 104–107 (1975)Google Scholar
  3. 3.
    BEREZIN, M.: Vitamins and diabetes mellitus. Diabetologia 10: 380 (1974)Google Scholar
  4. 4.
    BROWN, R.R.; PRICE, J.M.; FRIEDELL, G.H.; BURNEY, S.W.: Tryptophan metabolism in patients with bladder cancer: Geographical differences. J.Nat.Cancer Inst. 43: 295–301 (1969)PubMedGoogle Scholar
  5. 5.
    BYAR, H.L.; BLACKARD, C.: Comparisons of placebo, pyrido- xine, and topical thiotepa in preventing recurrence of stage I bladder cancer. Urology 10: 556–561 (1977)PubMedCrossRefGoogle Scholar
  6. 6.
    DAVIS, H.L.; BROWN, R.R.; LEKLEM, J.; CARLSON, I.H.: Tryptophan metabolism in breast cancer. Correlation with urinary steroid excretion. Cancer 31: 1061–1064 (1973)PubMedCrossRefGoogle Scholar
  7. 7.
    GAILANI, S.D.; HOLLAND, J.F.; NUSSBAUM, A.; OLSON, K.B.: Clinical and biochemical studies of pyridoxine deficiency in patients with neoplastic diseases. Cancer 21: 975–988 (1968)PubMedCrossRefGoogle Scholar
  8. 8.
    HA, C.; KERKVLIET, N.I.; MILLER, L.T.: The effects of vitamin B6 deficiency on host susceptibility to moloney sarcoma virus-induced tumor growth in mice. J.Nutr.114: 938–945 (1984)PubMedGoogle Scholar
  9. 9.
    LADNER, H.-A.; SCHWEIKERT, C.H.: Zur Wirksamkeit resistenzsteigernder Substanzen bei Strahlenbelastung und Trauma. In: Melching, H.-J, et al. (eds.): Strahlenschutz in Forschung und Praxis 4: 299–302 (1964) Rombach, FreiburgGoogle Scholar
  10. 10.
    LADNER, H.-A.: VON DÜSTERLHO, R.: Zur Strahlenschutz- wirkung des Pyridoxal-5-phosphats. Naturwissenschaften 51: 407 (1964)CrossRefGoogle Scholar
  11. 11.
    LADNER, H.-A.; VAN DE WEYER, K.H.: Zur Erkennung strahleninduzierter Vitamin B6.-Mangelzustände beim Menschen. Fortsehr.Röntgenstr. 112: 382–388 (1970)CrossRefGoogle Scholar
  12. 12.
    LADNER, H.-A.; HOLTZ, F.: Zum Verhalten einiger B-Vitamine nach Strahlen und/oder Zytostatikabehandlung gynäkologischer Karzinome. In: Wannenmacher, M.; Gauwerky, F.; Streffer, Ch. (eds.). Kombinierte Strahlen- und Chemotherapie. Urban u. Schwarzenberg, München- Wien-Baltimore 191–195 (1979)Google Scholar
  13. 13.
    LADNER,H.-A.; MITCHELL, J.S.; KING, E.A.; WEISSELBERG, R.: Das Verhalten einiger B-Vitamine beim Karzincmpatien- ten während der Strahlentherapie. Strahlentherapie 156: 856–860 (1980)PubMedGoogle Scholar
  14. 14.
    LANGENDORFF, H.; MELCHING, H.-J.; RÖSLER, H.: Untersuchungen über einen biologischen Strahlenschutz. XXXVII.Mitteilung: Über den Anteil des Adenylsäure- systems und des Pyridoxal-5-phosphats am Strahlenschutz- effekt des Serotonins. Strahlentherapie 113: 603–609 (1960)PubMedGoogle Scholar
  15. 15.
    LANGENDORFF, H.; SCHEUERBRANDT, G.; STREFFER, Ch.; MELCHING;H.-J.: Die Wirkung einer Ganzkörperbestrahlung von Mäusen auf die Aktivität der Dekarboxylase aromatischer Aminosäuren in Leber und Milz. Naturwissenschaften 51: 290–291 (1964)CrossRefGoogle Scholar
  16. 16.
    MELCHING, H.-J.: Zur Frage einer Beeinflussung der Strahlenempfindlichkeit bei Säugetieren. Strahlentherapie 120: 34–73 (1963)PubMedGoogle Scholar
  17. 17.
    POTERA, C.; ROSE, D.P.; BROWN, R.R.: Vitamin B6. deficiency in cancer patients. Am.J.Clin.Nutr. 30: 1677–1679 (1977)PubMedGoogle Scholar
  18. 18.
    RIVLIN, R.S.: Riboflavin and cancer. In: Rivlin, R.S.(ed): Riboflavin, Plenum press, New York and London. 369–391 (1975)CrossRefGoogle Scholar
  19. 19.
    ROBSON, L.C.; SCHWARZ, M.R.: The effects of vitamin B6 deficiency on the lymphoid system and immune responses. In: Tryfiates, G.B. (ed): Vitamin B6 metabolism and role in growth. Food and Nutrition press, Westport 205–222 (1980)Google Scholar
  20. 20.
    ROSE, D.P.: Oral contraceptives and vitamin B6. In: Human vitamin B6 requirements. National academy of sciences, Washington, 193–201 (1978)Google Scholar
  21. 21.
    STREFFER, Ch.: Zum Stoffwechsel der Aminosäuren und Proteine nach Bestrahlung von Säugetieren. In: Gerber, G.B.; Ladner, H.-A.; Rausch, L; Streffer, Ch (eds): Biochemisch nachweisbare Strahlenwirkungen und deren Beziehungen zur Strahlentherapie. G.Thieme, Stuttgart 51–63 (1970)Google Scholar
  22. 22.
    SPANNUTH, C.L.; MITCHEL, D.;STONE, W.J.; SCHENKER, S.; WAGNER, C.: Vitamin B6 nutriture in patients with uremia and with liver diasease. In: Human vitamin B6 requirements. National Academy of Sciences, Washington, 180–192 (1978)Google Scholar
  23. 23.
    TRYFIATES, G.P.; MORRIS, H.P.; SONIDIS, G.P.: Vitamin B6 and cancer (Review). Anticancer Res. 1: 263–268 (1981)PubMedGoogle Scholar
  24. 24.
    DE VITA, V.T.; CHABNER, B.A.; LI VINGSTON, D. M.; OLIVERIO, V.T.: Anergy and tryptophan metabolism in Hodgkis disease. Am.J.Clin.Nutr. 24: 835–840 (1971)Google Scholar
  25. 25.
    VUILLEUMIER, J.P.; KELLER, H.E., RETTTENMEIER, R; HUN- ZIKER,F.: Clinical chemical methods for the routine assessment of the vitamin status in human populations Part lis The water-soluble vitamin B1 B2 and B6 Internat.J.Nutr.Res. 53: 359–370 (1983) Google Scholar
  26. 26.
    WESTPHAL, H.M., BEATO, M.: Influence of pyridoxal-5-phos- phate on the DNA-binding activity of steroid hormone receptors and other DNA binding proteins. FEBS Letters 124: 189–192 (1981)PubMedCrossRefGoogle Scholar
  27. 27.
    WOLF, H.: Studies on tryptophan metabolism in man. Scand.J.Clin.Lab.Invest. 33: Suppl. 136 (1974)Google Scholar

Copyright information

© The Humana Press Inc. 1986

Authors and Affiliations

  • H.-A Ladner
    • 1
  • R. M. Salkeld
    • 1
  • H.-A Ladner
    • 1
  1. 1.Dpt.of gynecol.RadiologyUniversity of FreiburgW.-Germany

Personalised recommendations